CAR-T cell therapy in china: innovations, challenges, and strategic pathways

CAR-T cell therapy in china: innovations, challenges, and strategic pathways

Abstract Cancer immunotherapy has transformed oncology, with CAR-T cell therapy emerging as a cornerstone of personalized treatment for hematologic malignancies. In China, rapid advancements in domestically developed CAR-T therapies have achieved clinical outcomes comparable to global benchmarks, wi...

Full description

Saved in:
Bibliographic Details
Main Authors: Lihui Yan, Boshi Duan, Peng Sun, Tianzuo Wang, Tianyou Wang, Shuang Jiang, Yue Wang
Format: Article
Language:English
Published: Springer 2025-08-01
Series:Discover Oncology
Subjects:
Tumor immunotherapy
Immune cell therapy
Immune checkpoint therapy
CAR-T
Bispecific antibodies
Online Access:https://doi.org/10.1007/s12672-025-03282-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s12672-025-03282-9

Similar Items